Search results
Results from the WOW.Com Content Network
Journal Citation Reports (JCR) is an annual publication by Clarivate. [1] It has been integrated with the Web of Science and is accessed from the Web of Science Core Collection. It provides information about academic journals in the natural and social sciences, including impact factors. JCR was originally published as a part of the Science ...
The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science.
Drug Design, Development and Therapy; Drug Development and Industrial Pharmacy; Drug Discovery Today; Drug, Healthcare and Patient Safety; Drug Safety; Drug Metabolism Reviews; Drug Testing and Analysis; European Heart Journal - Cardiovascular Pharmacotherapy; European Journal of Pharmaceutical Sciences; European Journal of Pharmaceutics and ...
The four journals cover developments across the breadth of therapeutic areas and technologies relevant to the drug discovery and development pipeline. However, as of 2022, these titles have been discontinued and incorporated back into Drug Discovery Today. According to the Journal Citation Reports, the journal has a 2022 impact factor of 8.2. [1]
Journal of Functional Biomaterials: 2010 2079-4983 Journal of Functional Morphology and Kinesiology: 2016 2411-5142 Journal of Fungi: 2015 2309-608X Journal of Imaging: 2015 2313-433X Journal of Intelligence: 2013 2079-3200 Journal of Low Power Electronics and Applications: 2011 2079-9268 Journal of Manufacturing and Materials Processing: 2017 ...
The simplest journal-level metric is the journal impact factor, the average number of citations that articles published by a journal in the previous two years have received in the current year, as calculated by Clarivate. Other companies report similar metrics, such as the CiteScore, based on Scopus.
It was established in 2002 [1] and covers drug discovery and development. The editor-in-chief is Peter Kirkpatrick. [ 2 ] According to the Journal Citation Reports , the journal has a 2021 impact factor of 112.288, ranking it 1st out of 158 journals in the category "Biotechnology & Applied Microbiology" [ 3 ] and 1st out of 279 journals in the ...
According to the Journal Citation Reports, the journal has a 2014 impact factor of 2.495, ranking it 27th out of 59 journals in the category "Chemistry, Medicinal" [2] and 163 out of 289 journals in the category "Biochemistry & Molecular Biology". [3] The editor-in-chief is Mike Waring (Newcastle University). [4]